MedTrace Logo

Sexual Health and Rehabilitation After Ovarian Suppression Treatment

NCT03571841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-11-12

No results posted yet for this study

Summary

This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.

Conditions

  • Breast Cancer Survivors
  • Sexual Function Disturbances
  • Ovarian Suppression Treatment

Interventions

BEHAVIORAL

Group Session

The 4-hour group session will be structured around three 60-minute modules and creation of a personal action plan

BEHAVIORAL

Telephone Booster

One month following the group session, women will receive a telephone booster session (\<15 minutes). This brief telephone check-in is intended to help women review progress with their individualized action-plan, problem-solve around continuing problems, and plan for maintenance moving forward.

Sponsors & Collaborators

Principal Investigators

  • Sharon Bober, Ph.D · Dana-Farber Cancer Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-12-01
Completion
2019-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571841 on ClinicalTrials.gov